FDA Awards Grants for Clinical Trials to Stimulate Product Development for Rare Diseases

October 25, 2017 – The U.S. Food and Drug Administration (FDA) has awarded numerous new clinical trial research grants, totaling more than $22 million over the next 4 years, to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country. “Given the often small number of patients facing certain rare diseases, there can be limited resources devoted to … (leggi tutto)